hydroxy-2-naphthalenyl-methyl phosphonic acid trisacetoxymethylester has been researched along with Kaposi Sarcoma in 1 studies
hydroxy-2-naphthalenyl-methyl phosphonic acid trisacetoxymethylester : An organic phosphonate that is the trisacetoxymethylester derivative of naphthalene substituted hydroxymethylphosphonic acid. It has been found to inhibit insulin receptor tyrosine kinase activity and insulin stimulated glucose oxidation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rose, PP | 1 |
| Carroll, JM | 1 |
| Carroll, PA | 1 |
| DeFilippis, VR | 1 |
| Lagunoff, M | 1 |
| Moses, AV | 1 |
| Roberts, CT | 1 |
| Früh, K | 1 |
1 other study available for hydroxy-2-naphthalenyl-methyl phosphonic acid trisacetoxymethylester and Kaposi Sarcoma
| Article | Year |
|---|---|
The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma.
Topics: Cell Line, Transformed; Cell Transformation, Viral; Endothelial Cells; Herpesvirus 8, Human; Humans; | 2007 |